Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks.

FDA clears AI screening tool for cardiac amyloidosis
Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA's breakthrough device designation back in 2023.
Are providers too trusting of AI's advice?
“When we rely too much on whatever the computer tells us, that’s a problem."
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
By expediting communication between radiologists and referring providers when suspicious findings are identified, the system has great potential to improve clinical outcomes in real-world scenarios, authors of a new study in JACR suggest.
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
A new analysis in Academic Radiology dives into the importance of finding balance between reducing radiation exposure while maintaining image quality.
New study highlights the need to include more challenging datasets in AI training
A recent analysis of an already CE-marked, AI-based system that identifies pneumothorax on chest radiographs revealed a weak point in what has largely been considered a reliable support tool.

McKesson hires American Airlines CFO

McKesson Corp. has chosen Jeffrey C. Campbell as its new senior vice president and CFO.

November 25, 2003

NovaRad names new VP of sales and marketing

PACS and RIS developer NovaRad has hired Robert Ahlman as its vice president of sales and marketing. PACS and RIS developer NovaRad has hired Robert Ahlman as its vice president of sales and marketing.

November 20, 2003

Amersham names Health President Peter Loescher as COO

Amersham plc has chosen Peter Loescher as COO, effective Jan. 1, 2004.

November 20, 2003

Confirma Inc. this week unveiled three promotions

Dan Bickford has been elevated to vice president of sales and marketing. Prior to Confirma, Bickford served in senior sales and marketing positions with NexCura Inc., ESC Medical Systems and Neopath (now Tripath).

November 13, 2003

Epix Medical President and COO Knight resigns

Epix Medical Inc. this week announced the departure of President and COO Stephen C. Knight, M.D.

November 13, 2003

GEMSIT's Wilson named chairman of Instrumentarium

Dow Wilson, who has served as president and CEO of GE Medical Systems Information Technologies (GEMSIT) since May, has been named chairman of the board of Instrumentarium Corp.

November 6, 2003

Barco names Orth Business Development Manager

Barco recently named Alan Orth as its new business development manager for its new medical modality business in North America.

October 23, 2003

Misys names Pat McNamee president of Physicians Systems

Misys Healthcare Systems has named Pat McNamee as president of its Physicians Systems business.

October 16, 2003

Around the web

Cardiovascular Business

Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

Artificial Intelligence

FDA clears AI screening tool for cardiac amyloidosis

Are providers too trusting of AI's advice?

Pairing an alert system with CAD software halves time-to-treatment for pneumothorax

Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams

New study highlights the need to include more challenging datasets in AI training

Around the web